EUVIMEDEUVIMED entdecken
Crossref

Mohs Micrographic Surgery Efficacy for Solid Organ Transplant Head and Neck Cutaneous Squamous Cell Carcinoma

Kevin L Li, Cecelia E Schmalbach

Otolaryngology–Head and Neck Surgery · 2025-04 · 172 (4) · 1286-1290

DOI: 10.1002/ohn.1129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, online erschienen am 10.01.2025. Verfasst von Kevin L Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Mohs Surgery, Skin Neoplasms, Organ Transplantation, Head and Neck Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Solid organ transplant (SOT) recipients carry a higher incidence of cutaneous squamous cell carcinoma (cSCC) with more aggressive features and worse outcomes compared to immunocompetent (IC) patients. The National Comprehensive Cancer Network advocates peripheral and deep en‐face margin assessment such as Mohs micrographic surgery (MMS) for very‐high‐risk cSCC. We aim to assess the efficacy of MMS in the treatment of SOT immunosuppressed head and neck (HN) cSCC patients. Study Design Cohort study with planned chart review enrolling HN cSCC patients (2004‐2017).

Setting

Patients were enrolled from a tertiary care medical center registry.

Methods

Patients with cSCC were categorized on the independent variable of immune status. The incidence of MMS was compared between IC and SOT patients. Subgroup analysis of a matched cohort of patients treated with only MMS was performed for patient demographics, tumor characteristics, recurrence rates, and survival.

Results

A total Of 178 HN cSCC patients met the criteria. SOT patients were more likely to be treated with MMS, P < .001. In the subgroup analysis, 34 matched patients were treated with MMS alone. There was homogeneity between groups regarding patient demographics and tumor characteristics. One patient developed local recurrence in the SOT cohort ( P = .310). Compared to IC cSCC patients, SOT patients treated with MMS did not experience worse disease‐free or overall survival (OS) ( P = .540).

Conclusion

This study suggests that narrow‐margin MMS is an appropriate treatment option for SOT cSCC patients. SOT patients were more likely to be treated with MMS and did not compromise local recurrence, disease‐free, or OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mohs SurgerySkin NeoplasmsOrgan TransplantationHead and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckCarcinoma, Squamous CellHumansMaleFemaleMiddle AgedAgedTreatment OutcomeRetrospective StudiesImmunocompromised HostCohort Studies

Stichwörter der Autor:innen

Mohs micrographic surgerycutaneoushead and neckimmunosuppressionsolid organ transplantsquamous cell carcinoma

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Lewis Katz School of Medicine, Philadelphia, Pennsylvania, USA.

Zitieren

APA

Li, K. L., & Schmalbach, C. E. (2025). Mohs Micrographic Surgery Efficacy for Solid Organ Transplant Head and Neck Cutaneous Squamous Cell Carcinoma. Otolaryngology–Head and Neck Surgery, 172(4), 1286-1290. https://doi.org/10.1002/ohn.1129

Vancouver

Li KL, Schmalbach CE. Mohs Micrographic Surgery Efficacy for Solid Organ Transplant Head and Neck Cutaneous Squamous Cell Carcinoma. Otolaryngology–Head and Neck Surgery. 2025;172(4):1286-1290. doi:10.1002/ohn.1129

BibTeX
@article{Li2025,
  author = {Li, Kevin L and Schmalbach, Cecelia E},
  title = {Mohs Micrographic Surgery Efficacy for Solid Organ Transplant Head and Neck Cutaneous Squamous Cell Carcinoma},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2025},
  volume = {172},
  number = {4},
  pages = {1286--1290},
  doi = {10.1002/ohn.1129}
}
Kostenlos starten →